🔴 Senti Biosciences is trading 5.82% down in pre-market amid broader biotech weakness

Senti Biosciences is trading 5.82% lower at $0.21 in pre-market, with sector weakness a possible factor but no confirmed company-specific catalyst.

• XBI is down 3.65% pre-market, while broader indices are also lower.
• The shareholder-approved merger and potential reverse split were reported on October 16, not as a new catalyst today.